Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
WITHDRAWN
NA
INTERVENTIONAL
2025-03-01
2025-09-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Exercise in Perimenopause to Improve Cognitive Health
NCT07272174
Female Muscle Enhancement
NCT05397418
Resistance Exercise Training on Vascular and Physical Function in Postmenopausal Women
NCT06958965
The Clinical Utility of Resistance Training for Improving Cardiovascular Disease Risk in Post-Menopausal Women
NCT03752060
Effect of Different Exercise Modalities on Cardiovascular and Cognitive Response in Postmenopausal Women
NCT06533982
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
OTHER
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
First wave of participants (n=30)
This arm is the first round of the exercise intervention, conducted with half (n=30) the anticipated number of participants.
Heavy resistance training
The heavy resistance training intervention will consist of twice weekly exercise sessions of 60 minutes each.
Yoga
Twice weekly yoga sessions of 60 minutes each
Second wave of participants (n=30)
This arm is the second round of participants (n=30) who will receive the same intervention as the first wave.
Heavy resistance training
The heavy resistance training intervention will consist of twice weekly exercise sessions of 60 minutes each.
Yoga
Twice weekly yoga sessions of 60 minutes each
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Heavy resistance training
The heavy resistance training intervention will consist of twice weekly exercise sessions of 60 minutes each.
Yoga
Twice weekly yoga sessions of 60 minutes each
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Currently experiencing symptoms related to menopause
* Low physical activity levels at study enrollment (not meeting CDC guidelines of 150 minutes moderate/75 minutes vigorous activity per week)
* No regular (\>1x per week) participation in heavy resistance training or yoga exercise within the past 6 months
* Physician's consent to participate in strength testing and the exercise program (if deemed necessary)
* Ambulatory
* Absence of health conditions that may be exacerbated by exercise
* Good or corrected vision and hearing
* Intention to remain in the Boston area for the duration of the study
* Willingness to complete study assessments
* Ability to read, write and understand English
* Not currently enrolled in another PA study
Exclusion Criteria
* Pregnant or planning to become pregnant
* Moderate to high physical activity levels at enrollment (meeting CDC guidelines)
* Currently participating regularly (\>1x per week) in a heavy resistance training or yoga program
* Non-consent of physician (if deemed necessary)
* Non-ambulatory (e.g. use of walkers, wheelchairs)
* Presence of health conditions that may be exacerbated by exercise (arthritis, musculoskeletal disorders, etc.)
* Problems with vision or hearing
* Intent to move or take an extended (\>2 weeks) vacation during the testing time points (baseline, 4 months)
* Unwilling to complete study assessments
* Currently enrolled in another PA study
40 Years
60 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Northeastern University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Northeastern University
Boston, Massachusetts, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IRB# 24-12-12
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.